Evexia Lifecare shares are in focus on the back of a bulk deal. According to BSE data, LTS Investment Fund has added additional shares of the company in a bulk deal on Tuesday.
The fund bought as many as 40 lakh shares of the company which is a leading manufacturer of pharma and agricultural chemicals. The transaction was executed at Rs 2.69 per share, BSE data showed.
The comes close on the heels of the fund picking 55 lakh shares of the company earlier this month at an average price of Rs 2.45.
Meanwhile, shares of Evexia Lifecare on Wednesday locked in the upper circuit on the BSE. The stock has appreciated 44 per cent in the last one month and 55 per cent in six months period. It has rallied a massive 81 per cent in 2023 so far, according to BSE data.
Evexia Lifecare had in May last year split its equity shares having a nominal value of Rs 2 each. After the sub-division, the face value of each share became Re 1. In 2021 as well, the company had split its equity shares having a face value of Rs 10 each. The sub-division had taken place in 5:1 ratio. Back in 2015, the company had issued bonus share to its investors in the ratio of 1:3.
According to shareholding pattern in NSE, promoters have 9.87 per cent stake in the company while public and FIIs have 83.08 per cent and 6.79 per cent ownerships, respectively.
Evexia Lifecare manufactures various petrochemical downstream products, such as special oils, special chemicals, petroleum sulphates and solvents for industrial applications, such as rubber, leather, ink and paint industries. Its products include edible oil, pharma intermediates, plastic granule, chemicals, and gold and diamond. The company has a market cap of Rs 189 crore.
ALSO READ: Go First crisis: Aircraft lessors approach DGCA to deregister 45 planes | DETAILS
ALSO READ: Telecom Dept deactivates 2.25 lakh mobile numbers in Bihar & Jharkhand
